Top

Drugs

Published in:

01-12-2003 | Adis Drug Profile

Azelnidipine

A Viewpoint by Yukihito Higashi

Author: Yukihito Higashi

Published in: Drugs | Issue 23/2003

Excerpt

Azelnidipine is a new dihydropyridine calcium channel antagonist that is selective for L-type calcium channels. In patients with hypertension, a single dose of orally administered azelnidipine 8mg reaches peak plasma concentrations at 3.7 hours and has a plasma half-life of about 6 hours. This drug has a slow and persistent hypotensive effect, and does not affect the circadian rhythm of blood pressure. Azelnidipine, like amlodipine, is a third-generation dihydropyridine calcium antagonist. …

Title: Azelnidipine
A Viewpoint by Yukihito Higashi
Author: Yukihito Higashi
Publication date: 01-12-2003
Publisher: Springer International Publishing
Published in: Drugs / Issue 23/2003
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI: https://doi.org/10.2165/00003495-200363230-00005

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Azelnidipine

A Viewpoint by Yukihito Higashi

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 23/2003

Vardenafil

Azelnidipine

Erratum to: Tadalafil

Levosimendan

Azelnidipine

Phosphodiesterase-4 Inhibitors in the Treatment of Inflammatory Lung Disease